SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

CEO Troy Wilsons repeated open-market purchases of 100,000 shares have driven attention, with traders viewing the insider buying as a confidence signal and potential support for Kuras commercial launch and AML pipeline. Some remain cautious about valuation, cash burn, execution risk and the need for further KOMZIFTI sales growth and clinical data.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The token is drawing attention amid a prolonged collapse from its launch-era peak, with traders largely debating whether it was a Trump-family-linked pump-and-dump and criticizing its lack of utility. A smaller bullish group is promoting dip-buying and a potential rebound, but bearish sentiment dominates.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforces strong quarterly results, raised outlook and expanded Anthropic partnership through Claudeforce have driven a sharp re-rating and renewed confidence that AI can augment rather than replace enterprise SaaS. Traders are broadly bullish and citing short covering and a broader software rotation, while skeptics argue the move is overextended and that buybacks, investments and acquisitions flatter underlying organic growth.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

The Ninth Circuits ruling that sports-event contracts are bets rather than federally regulated swaps is being viewed as a regulatory win for DraftKings, potentially limiting Kalshi and other prediction-market competition and strengthening licensed sportsbooks moat. Traders are broadly bullish on the implications, though some remain cautious about the circuit split, possible Supreme Court review, prediction-market execution, and the stocks history of failing to hold gains.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canadas sale of a minority stake in Aeroplan, combined with stronger-than-expected quarterly results and resilient travel demand, has focused attention on value unlocking, debt reduction and accelerated share buybacks. Traders are largely bullish, though some remain concerned about elevated fuel and labor costs and the airlines ongoing net debt burden.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Natural-gas storage injections, elevated production and Freeport LNG maintenance are driving the dominant bearish discussion around BOIL, with traders arguing these supply factors are outweighing summer heat and power demand. Others anticipate a rebound if upcoming storage draws strengthen or Freeport exports recover, while many stress that contango and leveraged decay make BOIL a short-term trading vehicle rather than a long-term hold.

ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

Expectations for continued natural-gas weakness are driving interest in KOLD, with traders citing above-average storage, strong production, cooling weather, and reduced LNG exports during Freeport maintenance. Some participants still expect heat-driven rebounds or short squeezes, but the dominant view favors KOLD as a short-term hedge against seasonal oversupply and bearish EIA storage data.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Anticipation of Intellia completing its rolling BLA for lonvo-z, following positive Phase 3 HAELO results in hereditary angioedema, is driving attention as traders look toward potential FDA acceptance and commercialization. The community is largely bullish on the therapys one-time gene-editing potential, while bearish participants emphasize financing, commercialization risk, and heavy short interest.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Completion of ANKTIVAs first German labeling and packaging run is fueling attention as ImmunityBio advances its European commercial rollout. Traders view Germany as a key step toward broader international revenue, while debate continues over speculative UAE/Saudi approvals and whether heavy short interest could amplify the move.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

The scheduled quarterly earnings report is the main catalyst, with traders focused on whether AI-server demand, backlog, margins and forward guidance will support Dells elevated valuation. The community is divided between bulls expecting another strong result and bears warning of an overextended, potentially sell-the-news rally, while strong results from Lenovo and Super Micro are being used as supportive sector read-throughs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JPMorgans reduction of lithium profit estimates, citing retreating lithium prices, is driving attention and renewed volatility in ALB. Traders are divided between viewing the downgrade as an opportunity to add on weakness and remaining cautious that the stock remains highly dependent on lithium pricing and battery demand.

ALB vs. SQM: Which Lithium Stock Should You Bet on Now?

ALB and SQM are ramping capacity and expanding output as EV and storage demand accelerates.

Albemarle's Lithium Math Turns Brutal

Albemarle (ALB) stock dipped as JPMorgan cut earnings estimates and its price target to $140 over lower lithium prices.read more...

Stock of the Day: Is This the Top for Albemarle?

Albemarle shares are consolidating. Psychological and emotional factors among traders often drive stock movements.read more...

Will Albemarle's Cash Strength Support Higher Shareholder Returns?

ALB's $3.2B liquidity, surging cash flow and rising lithium prices could fuel stronger shareholder returns.

The Zacks Analyst Blog Highlights Albemarle, Sociedad Quimica and Rio Tinto

Albemarle's shares have slumped as lithium prices retreat, but rising demand, project ramp-ups and productivity gains support its long-term outlook.

Albemarle Stock Slides 28% in 3 Months: Should You Buy the Dip?

ALB's 28% slide reflects weak lithium prices and near-term margin pressure, but project ramp-ups and cost savings offer support.

ALB Q2 Earnings Call Highlights Storage Demand, Q3 Pressure

Albemarle sees tight lithium inventories and stronger storage demand, but warns Q3 Energy Storage sales, EBITDA and margins may decline sequentially.

ALB Q2 Earnings Beat Estimates on Lithium Pricing Strength

ALB beat Q2 earnings estimates as stronger lithium pricing, Specialties growth and productivity gains lifted sales, EBITDA and cash flow.

Albemarle (ALB) Q2 Earnings and Revenues Surpass Estimates

Albemarle (ALB) delivered earnings and revenue surprises of +11.94% and +9.94%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Albemarle (ALB) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Albemarle (ALB) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

• Reported GAAP EPS of $3.72 up 2425.00% YoY
• Reported revenue of $1.74B up 31.08% YoY
• Albemarle Corporation expects full-year 2026 capital expenditures of approximately $500 million, while increasing the Specialties net sales outlook to $1.4 to $1.6 billion and adjusted EBITDA to $275 to $325 million.

Albemarle Corporation faces operational headwinds including a fire-related delay at the Talison CGP3 site, persistent geopolitical tensions in the Middle East, and expected softness in automotive and petrochemical end markets.

Albemarle Corporation delivered strong quarterly results with 31% net sales growth and a 155% increase in adjusted EBITDA, while simultaneously improving capital efficiency and achieving significant year-to-date cost productivity improvements.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

This Lithium Company Surged To A 52-Week High Today — Here’s Why

Equity

Neutral Sentiment

Track ALB stock price, charts, news and real-time market activity on Stocktwits. Join the ALB message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Albemarle Corp stock.

ALB Stock Price Today - Albemarle Corp News, Charts, Retail Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$2.56	--	--	N/A
Q2 '26	$3.20	$3.75	17.09%	BEAT
Q1 '26	$1.19	$2.95	147.03%	BEAT
Q4 '25	-$0.42	-$0.53	-26.85%	MISSED
Q3 '25	-$0.86	-$0.19	77.94%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings